Posted in | News | Business

Juhani Taskinen to lead Picosun’s New PicoMedical Business Area

ESPOO, Finland, 16th December 2020 – Picosun Group, the leading supplier of AGILE ALD® (Atomic Layer Deposition) thin film coating technology, has established a new business area, PicoMedical, for medical and healthcare ALD segments.

The newly established business area will reinforce and streamline Picosun Group’s activities in the medical field. These activities include product and solutions development for medical ALD applications, driving the profitable growth from the medical segment, and increasing the Picosun brand awareness in the healthcare and medical industries. PicoMedical will also manage the Group’s extensive medical ALD patent portfolio of 18 patent families, and coordinate and execute research activities and collaboration projects in the medical field.

Picosun has appointed Mr. Juhani Taskinen to lead the PicoMedical business area. The appointment was made in the Picosun Board meeting. Mr. Taskinen will start in his position 5th January 2021. Mr. Taskinen has extensive international career and background in the medical field, and proven track record in driving profitable business growth and leading successful collaboration activities in these industries. He has held various leading general management, sales and marketing, and business development positions in pharma, biotech, and healthcare companies such as Johnson & Johnson, Merck, and Abbott.

“Right now, ALD is disrupting healthcare technologies just like it did to microelectronics in the early 2000’s. Picosun is the trailblazer and spearhead in medical ALD solutions. I’m happy to start in my new position as the head of Picosun’s PicoMedical business area to speed this company into even greater success in the healthcare segment,” states Mr. Taskinen.

“It’s great to welcome Mr. Juhani Taskinen into our team. ALD has amazing possibilities to offer to the healthcare industries. We are sure that with Mr. Taskinen’s skills, background and expertise we can truly make several new breakthroughs in this field,” continues Mr. Jussi Rautee, CEO of Picosun Group

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Picosun Oy. (2020, December 16). Juhani Taskinen to lead Picosun’s New PicoMedical Business Area. AZoM. Retrieved on November 24, 2024 from https://www.azom.com/news.aspx?newsID=55193.

  • MLA

    Picosun Oy. "Juhani Taskinen to lead Picosun’s New PicoMedical Business Area". AZoM. 24 November 2024. <https://www.azom.com/news.aspx?newsID=55193>.

  • Chicago

    Picosun Oy. "Juhani Taskinen to lead Picosun’s New PicoMedical Business Area". AZoM. https://www.azom.com/news.aspx?newsID=55193. (accessed November 24, 2024).

  • Harvard

    Picosun Oy. 2020. Juhani Taskinen to lead Picosun’s New PicoMedical Business Area. AZoM, viewed 24 November 2024, https://www.azom.com/news.aspx?newsID=55193.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.